Search PDMR transactions

Notifier
Name of person with notification obligation
Hangethe Consulting AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Patrik Fagerholm
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share NXTCL SE0009723125 Acquisition 15,000 Quantity 2.36 SEK 18/12/2024 FIRST NORTH SWEDEN
Subcription warrant NXTCL TO 2 SE0022240800 Acquisition 40,000 Quantity 0.625 SEK 18/12/2024 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NXTCL SE0009723125 Acquisition 18/12/2024 FIRST NORTH SWEDEN 15,000 (Quantity) 2.36 SEK
NXTCL TO 2 SE0022240800 Acquisition 18/12/2024 FIRST NORTH SWEDEN 40,000 (Quantity) 0.625 SEK
<< Back